Patents by Inventor Rafi Ahmed

Rafi Ahmed has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240126757
    Abstract: A new type of table join operation, outer semi join (OSJ), is provided, which can be used by an optimizer layer and an execution layer of a database management system (DBMS). OSJ combines the semantics of both left outer-join and semi-join. The concept of an anti-join marker (AJM) is also introduced, which specifies whether a matching row was not found between joined tables for each result row in an OSJ operation. The OSJ operation supports unnesting of a class of disjunctive ANY, ALL, EXISTS, NOT EXISTS, IN, and NOT IN subqueries for execution plan optimization. The disjunction may contain filter predicates. For unnesting, OSJ avoids the need of using a distinct operator on the right table and also supports using inequality (e.g. >, >=, <, <=) in connecting or correlating conditions of subqueries, rather than being limited to equality only.
    Type: Application
    Filed: October 14, 2022
    Publication date: April 18, 2024
    Inventors: Rafi Ahmed, Angela Amor, Mohamed Ziauddin
  • Publication number: 20240054131
    Abstract: Techniques for automatically partitioning materialized views are provided. In one technique, a definition of a materialized view is identified. Based on the definition, multiple candidate partitioning schemes are identified. A query is generated that indicates one or more of the candidate partitioning schemes. The query is then executed, where executing the query results in one or more partition counts, each corresponding to a different candidate partitioning scheme of the one or more candidate partitioning schemes. Based on the one or more partition counts, a candidate partitioning scheme is selected from among the plurality of candidate partitioning schemes. The materialized view is automatically partitioned based on the candidate partitioning scheme.
    Type: Application
    Filed: August 10, 2022
    Publication date: February 15, 2024
    Inventors: Rafi Ahmed, Randall Bello, Andrew Witkowski
  • Publication number: 20230303667
    Abstract: This disclosure relates to antibodies and antigen binding fragments that specifically bind Ebola virus particles. In certain embodiments, the antibodies and fragments are capable of treating or preventing an Ebola viral infection. In certain embodiments, the antibodies and antigen binding fragments are also contemplated for diagnostic methods and compositions related thereto.
    Type: Application
    Filed: June 9, 2023
    Publication date: September 28, 2023
    Inventors: Rafi Ahmed, Carl Davis, Erica Ollmann Saphire
  • Publication number: 20230266336
    Abstract: This disclosure relates to coronavirus assays, diagnostic methods, treatment methods, and compositions related thereto. In certain embodiments, this disclosure relates to ACE2 receptor binding domain peptides and uses in serological assays and vaccination methods.
    Type: Application
    Filed: May 3, 2021
    Publication date: August 24, 2023
    Inventors: Rafi Ahmed, Mehul Suthar, Jens Wrammert, John Roback, Robert Kauffman
  • Patent number: 11714810
    Abstract: Techniques are described herein for subquery removal given two set operation-based subqueries in a query, where one subquery contains the result of the other. The described optimization technique of subquery removal is enabled by join and set operation-based containment of the set operation-based subqueries where semantic equivalence can be established for a given pair of set operation-based subqueries when some table(s)—with associated join condition(s), correlation condition(s), and/or filter predicate(s)—in one subquery are not considered. Subquery removal reduces multiple access to the same table and multiple evaluations of the same join conditions required to evaluate the query. When a subquery is removed from a disjunction, this may lead to other optimizations such as subquery unnesting, e.g., when the original query configuration would not permit query unnesting and the rewritten query (with one or more removed subqueries) permits unnesting.
    Type: Grant
    Filed: March 25, 2021
    Date of Patent: August 1, 2023
    Assignee: Oracle International Corporation
    Inventors: Rafi Ahmed, Srikanth Bellamkonda
  • Patent number: 11713349
    Abstract: This disclosure relates to antibodies and antigen binding fragments that specifically bind Ebola virus particles. In certain embodiments, the antibodies and fragments are capable of treating or preventing an Ebola viral infection. In certain embodiments, the antibodies and antigen binding fragments are also contemplated for diagnostic methods and compositions related thereto.
    Type: Grant
    Filed: March 9, 2021
    Date of Patent: August 1, 2023
    Assignees: Emory University, The Scripps Research Institute
    Inventors: Rafi Ahmed, Carl Davis, Erica Ollmann Saphire
  • Patent number: 11615107
    Abstract: Definitions of material views are automatically generated. In general, Automated MV generation identifies a set of candidates MVs by examining a working set of query blocks. Once the candidates are formed, the candidate MVs are further evaluated to calculate a benefit to the candidate MVs. An improved approach for generating a candidate set of MVs is described herein. The improved approach is referred to as the extended covering subexpression technique (ECSE). Under ECSE, various relationships between join sets other than strict equivalence are used to generate new resultant join sets. Such relationships include subset, intersection, superset, and union, which shall be described in further detail below. In some cases, relationships among resultant join sets and initial join sets are considered to generate new resultant join sets. The final resultant join sets are then used to form a candidate set of MVs.
    Type: Grant
    Filed: July 26, 2019
    Date of Patent: March 28, 2023
    Assignee: Oracle International Corporation
    Inventors: Rafi Ahmed, Randall Bello, Andrew Witkowski
  • Publication number: 20230024553
    Abstract: Techniques for subsumption of inline views and subqueries in a query are described. An optimization technique of subsumption is enabled by inline views having identical tables and identical join conditions and having aggregation functions but no group-by clauses. When subsumption takes place, a single query block replaces the inline views (or subqueries) with a single inline view query block. Subsumption reduces multiple access to the same table and multiple evaluations of the same join conditions required to evaluate the query. The single query block includes factored out filter predicates and unified predicates that originate from the subsumed inline views (or subqueries). Based on similarities among the aggregation functions and filter predicates in the subsumed inline views, pre-computation of common aggregates may be performed in a new group-by view in the subsuming view.
    Type: Application
    Filed: July 20, 2021
    Publication date: January 26, 2023
    Inventors: Rafi Ahmed, Mohamed Ziauddin, Sankar Subramanian
  • Publication number: 20220309062
    Abstract: Techniques are described herein for subquery removal given two set operation-based subqueries in a query, where one subquery contains the result of the other. The described optimization technique of subquery removal is enabled by join and set operation-based containment of the set operation-based subqueries where semantic equivalence can be established for a given pair of set operation-based subqueries when some table(s)—with associated join condition(s), correlation condition(s), and/or filter predicate(s)—in one subquery are not considered. Subquery removal reduces multiple access to the same table and multiple evaluations of the same join conditions required to evaluate the query. When a subquery is removed from a disjunction, this may lead to other optimizations such as subquery unnesting, e.g., when the original query configuration would not permit query unnesting and the rewritten query (with one or more removed subqueries) permits unnesting.
    Type: Application
    Filed: March 25, 2021
    Publication date: September 29, 2022
    Inventors: Rafi Ahmed, Srikanth Bellamkonda
  • Patent number: 11359013
    Abstract: The present invention provides methods and compositions for the treatment, prevention, or reduction of persistent infections, such as chronic infections, latent infections, and slow infections and cancer. The methods and compositions of the invention are also useful for the alleviation of one or more symptoms associated with such infections and cancer.
    Type: Grant
    Filed: June 18, 2019
    Date of Patent: June 14, 2022
    Assignees: Emory University, Dana-Farber Cancer Institute, Inc., Brigham and Women's Hospital, Inc., President and Fellows of Harvard College
    Inventors: Gordon Freeman, Arlene Sharpe, David M. Dorfman, Rafi Ahmed, Daniel Barber, E. John Wherry
  • Patent number: 11261251
    Abstract: The present invention is based, in part, on the identification of novel human anti-PD-1, PD-L1, and PD-L2 antibodies. Accordingly, the invention relates to compositions and methods for diagnosing, prognosing, and treating conditions that would benefit from modulating PD-1, PD-L1, and/or PD-L2 activity (e.g., persistent infections diseases, autoimmune diseases, asthma, transplant rejection, inflammatory disorders and tumors) using the novel human anti-PD-1, PD-L1, and PD-L2 antibodies described herein.
    Type: Grant
    Filed: July 9, 2019
    Date of Patent: March 1, 2022
    Assignees: DANA-FARBER CANCER INSTITUTE, INC., EMORY UNIVERSITY
    Inventors: Gordon J. Freeman, Rafi Ahmed, Timothy D. Jones, Francis J. Carr, James P. Gregson
  • Publication number: 20220041726
    Abstract: The present invention relates to methods of reducing liver PD-1-expressing CD8+ T cells using PD-1 Fc fusion proteins that bind Fc receptors, as well as diagnostic, prognostic, therapeutic methods and compositions related thereto.
    Type: Application
    Filed: August 20, 2021
    Publication date: February 10, 2022
    Inventors: Gordon J. Freeman, Rafi Ahmed, Arlene H. Sharpe, Masao Hashimoto, Hyun T. Jin
  • Patent number: 11147870
    Abstract: This disclosure relates to specific binding agents to varicella-zoster virus proteins or glycoproteins. In certain embodiments the specific binding agents are antibodies and binding fragments thereof disclosed herein. In certain embodiments, this disclosure relates to methods of treating or preventing a varicella-zoster infection comprising administering an effective amount of a specific binding agent disclosed herein to a subject in need thereof.
    Type: Grant
    Filed: April 25, 2019
    Date of Patent: October 19, 2021
    Assignee: Emory University
    Inventors: Rafi Ahmed, Nicole Sullivan
  • Patent number: 11124569
    Abstract: The present invention relates to methods of reducing liver PD-1-expressing CD8+ T cells using PD-1 Fc fusion proteins that bind Fc receptors, as well as diagnostic, prognostic, therapeutic methods and compositions related thereto.
    Type: Grant
    Filed: September 16, 2016
    Date of Patent: September 21, 2021
    Assignees: Dana-Farber Cancer Institute, Inc., President And Fellows Of Harvard College, Emory University
    Inventors: Gordon J. Freeman, Rafi Ahmed, Arlene H. Sharpe, Masao Hashimoto, Hyun T. Jin
  • Publication number: 20210275592
    Abstract: This disclosure relates to the genetic modification of DNMT3A gene in immune cells. In certain embodiments, the modified immune cells may be used in adoptive T cells therapies to enhance immune responses against cancer or chronic infections. In certain embodiments, the disclosure relates to deleting, changing, or inserting nucleotides within the DNMT3A gene in immune cells, e.g., human CD8 T cells, such that the DNMT3A gene product does not function for methylation. In certain embodiments, modification of the DNMT3A gene provides an improvement in antigen-specific T cells functions and/or an enhancement of the longevity of the cells.
    Type: Application
    Filed: May 25, 2021
    Publication date: September 9, 2021
    Inventors: Rafi Ahmed, Benjamin Youngblood
  • Patent number: 11086868
    Abstract: A one-sided outer-join-based query is rewritten using a materialized view (MV), the definition of which includes the join but does not include a filter predicate from the query. The rewritten query nullifies data from the include-matching table, included in the MV, that does not satisfy the filter predicate. To improve accuracy of the query results, certain rows are removed from intermediate results of the query. To facilitate revising the query results for accuracy, the MV includes a unique column from the include-all table and also an indicator column that indicates whether a given row of the MV is an inner-join-type row or an anti-join-type row. The rewritten query adjusts the indicator values, in the indicator column, of MV rows that do not satisfy the filter to reflect a modified anti-join-type indicator value. Based on the modified indicator values and unique columns from include-all tables, accuracy of query results is attained.
    Type: Grant
    Filed: October 29, 2019
    Date of Patent: August 10, 2021
    Assignee: Oracle International Corporation
    Inventors: Rafi Ahmed, Randall Bello, Andrew Witkowski
  • Publication number: 20210221872
    Abstract: This disclosure relates to antibodies and antigen binding fragments that specifically bind Ebola virus particles. In certain embodiments, the antibodies and fragments are capable of treating or preventing an Ebola viral infection. In certain embodiments, the antibodies and antigen binding fragments are also contemplated for diagnostic methods and compositions related thereto.
    Type: Application
    Filed: March 9, 2021
    Publication date: July 22, 2021
    Inventors: Rafi Ahmed, Carl Davis, Erica Ollmann Saphire
  • Patent number: 11020430
    Abstract: This disclosure relates to the genetic modification of DNMT3A gene in immune cells. In certain embodiments, the modified immune cells may be used in adoptive T cells therapies to enhance immune responses against cancer or chronic infections. In certain embodiments, the disclosure relates to deleting, changing, or inserting nucleotides within the DNMT3A gene in immune cells, e.g., human CD8 T cells, such that the DNMT3A gene product does not function for methylation. In certain embodiments, modification of the DNMT3A gene provides an improvement in antigen-specific T cells functions and/or an enhancement of the longevity of the cells.
    Type: Grant
    Filed: November 4, 2016
    Date of Patent: June 1, 2021
    Assignees: Emory University, St. Jude Children's Research Hospital, Inc.
    Inventors: Rafi Ahmed, Benjamin Youngblood
  • Publication number: 20210124742
    Abstract: A one-sided outer-join-based query is rewritten using a materialized view (MV), the definition of which includes the join but does not include a filter predicate from the query. The rewritten query nullifies data from the include-matching table, included in the MV, that does not satisfy the filter predicate. To improve accuracy of the query results, certain rows are removed from intermediate results of the query. To facilitate revising the query results for accuracy, the MV includes a unique column from the include-all table and also an indicator column that indicates whether a given row of the MV is an inner-join-type row or an anti-join-type row. The rewritten query adjusts the indicator values, in the indicator column, of MV rows that do not satisfy the filter to reflect a modified anti-join-type indicator value. Based on the modified indicator values and unique columns from include-all tables, accuracy of query results is attained.
    Type: Application
    Filed: October 29, 2019
    Publication date: April 29, 2021
    Inventors: Rafi Ahmed, Randall Bello, Andrew Witkowski
  • Publication number: 20210026847
    Abstract: Definitions of material views are automatically generated. In general, Automated MV generation identifies a set of candidates MVs by examining a working set of query blocks. Once the candidates are formed, the candidate MVs are further evaluated to calculate a benefit to the candidate MVs. An improved approach for generating a candidate set of MVs is described herein. The improved approach is referred to as the extended covering subexpression technique (ECSE). Under ECSE, various relationships between join sets other than strict equivalence are used to generate new resultant join sets. Such relationships include subset, intersection, superset, and union, which shall be described in further detail below. In some cases, relationships among resultant join sets and initial join sets are considered to generate new resultant join sets. The final resultant join sets are then used to form a candidate set of MVs.
    Type: Application
    Filed: July 26, 2019
    Publication date: January 28, 2021
    Inventors: Rafi Ahmed, Randall Bello, Andrew Witkowski